<DOC>
	<DOC>NCT02115308</DOC>
	<brief_summary>The purpose of this study is to measure the changes in cardiac function during a Lexiscan pharmacologic stress test using cardiac magnetic resonance imaging test.</brief_summary>
	<brief_title>Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>Myocardial rest/regadenoson stress perfusion PET study within 60 days Normal rest LVEF (greater than or equal to 50%) No change in symptoms or treatment between the PET and the MRI study Willing to consent to the study Male or female who is either postmenopausal, surgically sterile, or if has a childbearing potential, a negative pregnancy test within 2 days prior to the MRI study. Renal dysfunction (estimated glomerular filtration rate &lt; 60 mL/min/1.73m2) within 6 months Metallic implants, pacemaker, blood vessel clip (contraindicated for MRI) Patient size exceeds MRI bore/table limits: (Max body diameter &gt; 60 cm, weight &gt; 136 kg) History of gadolinium contrast allergy or intolerance Second or third degree AV block Sinus node dysfunction Acute myocardial infarction (past 3 months) Actively wheezing or with acute asthma or bronchospastic attacks requiring changes in therapy within the past 30 days Patients that have experienced a previous hypersensitivity reaction thought to be related to regadenoson</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>